results

News

Veklury rescues Gilead from COVID doldrums in Q4

Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry on two HIV drugs, according to its

News

AZ's Q3 results disappoint - but COVID-19 vaccine trial is s...

AstraZeneca has posted an uninspiring set of quarterly results as it gears up for results from its closely watched coronavirus vaccine trial.

News

AZ shares slide after warning over coronavirus impact

Shares in AstraZeneca were sharply down this morning after it warned that the hit from the COVID-19 coronavirus could have an impact lasting a few months.

News

Sanofi Q1 growth driven by Genzyme

Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling.

News

Mylan reports lower than expected earnings

Mylan has reported lower than expected full year earnings and 2019 forecasts, thanks partly to delays in its generic Advair approval and continuing problems at its US manufacturing plant.

News